Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
Brendan D. Curti(Providence Portland Medical Center), William L. Redmond(Providence St. Vincent Medical Center)
Cited by 94
Related Papers
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869